VLV IL 12p35
Alternative Names: VLV-IL-12p35Latest Information Update: 28 Jun 2024
Price :
$50 *
At a glance
- Originator CaroGen
- Developer CaroGen; University of Connecticut
- Class Antineoplastics; Gene therapies; Immunotherapies
- Mechanism of Action Cell death stimulants; Helper-inducer T-lymphocyte stimulants; Interleukin-12 expression stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Colorectal cancer
Most Recent Events
- 28 Jun 2024 No recent reports of development identified for preclinical development in Colorectal-cancer in USA (Intratumoural)
- 29 May 2020 Pharmacodynamics data from preclinical studies in Colorectal cancer presented at the 56th Annual Meeting of the American Society of Clinical Oncology (ASCO-2020)